Uğur Yılmaz

Uğur Yılmaz

Auto-generated profile, based on publicly available information

Uğur Yılmaz

Department of Ophthalmology, Faculty of Medicine, Pamukkale University, Denizli, Turkey

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 December 2015 in European Journal of Ophthalmology
Verified
Journal Article
Closed access
UYUğur Yılmaz
Uğur Yılmaz
EKErkut Küçük
Erkut Küçük
AÜArzu Ülgen
Arzu Ülgen
AÖAyse Özköse
Ayse Özköse
SDSuleyman Demircan
Suleyman Demircan
GZGökmen Zararsız
Gökmen Zararsız
Purpose: To investigate the retina and macular thickness in patients with schizophrenia and to compare the results with those of healthy controls. Methods: Sixty-eight eyes of 34 patients with schizophrenia and 60 eyes of 30 randomly selected healthy volunteers were involved in the study. Measurements of peripapillary retinal nerve fiber layer (RNFL) thickness, macula thickness, and macula volume were taken in both eyes using spectral-domain optical coherence tomography (OCT). Statistical analysis was performed using Statistical Package for the Social Sciences version 20.0. Results: Average and nasal RNFL thicknesses were found to be significantly lower in the patient group than the control group (p = 0.030, p = 0.04, respectively). Macular thicknesses of nasal outer and inferior outer quadrants in the patient group were significantly lower than in the control group (p = 0.009, p = 0.027, respectively). Average macular thickness and macular thicknesses in the superior outer, superior inner, temporal outer, temporal inner, nasal inner, and inferior inner areas were lower in the patient group compared to the control group, but not significantly (p = 1.000, p = 1.000, p = 0.837, p = 1.000, p = 0.279, p = 1.000, p = 0.180, respectively). Conclusions: We detected RNFL and macular thinning in patients with schizophrenia. Based on these findings and results of other studies evaluating retina using OCT and brain magnetic resonance imaging studies in patients with schizophrenia, a neurodegenerative process may be an underlying pathologic mechanism in this disease.

1 December 2001 in Urology
Verified
Journal Article
Closed access
COCemal Ozcan
Cemal Ozcan
EOEmin Ozbek
Emin Ozbek
ASAhmet Soylu
Ahmet Soylu
UYUgur Yilmaz
Ugur Yilmaz
MGMehmet Guzelipek
Mehmet Guzelipek
MBMevlana Derya Balbay
Mevlana Derya Balbay

10 November 2016 in Journal of Dermatological Treatment
Verified
Journal Article
Closed access
UYUğur Yılmaz
Uğur Yılmaz
EKErkut Küçük
Erkut Küçük
ÇKÇağdaş Koç
Çağdaş Koç
AÖAyşe Özköse
Ayşe Özköse
Purpose: To investigate the effects of systemic isotretinoin therapy on retina by measuring retinal nerve fiber layer (RNFL) and macular thicknesses. Method: This prospective, cross-sectional study was conducted in patients prescribed systemic isotretinoin therapy. Seventy-two eyes of 36 patients were included in the study. The patients were followed during three months. Detailed ophthalmologic examination including anterior and posterior segment examination, best corrected visual acuity and intraocular pressure measurement, RNFL and macular thicknesses measurement by Spectral Domain Cirrus Optical Coherence Tomography Model 400 (Carl Zeiss Meditech, Jena, Germany) were performed at baseline, first, second and third months after the beginning of systemic isotretinoin therapy in ophthalmology clinic. Result: Thirty (83.3%) of the 36 patients were women and six (16.7%) of them were men. Mean age was 21.17 years. Mean RNFL thickness in the temporal quadrant at first, second, third months after beginning of treatment were found as significantly lower compared to baseline (p = .001). Mean macular thicknesses in superior outer, nasal outer and temporal outer quadrants at second and third months after beginning of treatment were found to be significantly lower compared to baseline and first month after beginning of treatment (p ≤ .001, .002 and .001, respectively). Macular thicknesses in superior inner quadrant at first, second and third months were found to be significantly lower than baseline values (p< .01). No significant difference was detected between groups in other quadrants (p> .05). Conclusion: The effect of oral isotretinoin therapy may cause regional thinning in RNFL and macula, directly visible part of central nervous system.

5 March 2010 in Digestion
Verified
Journal Article
Closed access
MDMehmet Cihat Demir
Mehmet Cihat Demir
SGSavaş Göktürk
Savaş Göktürk
NÖNevin Akçaer Öztürk
Nevin Akçaer Öztürk
ESEnder Serin
Ender Serin
UYUğur Yilmaz
Uğur Yilmaz
Background/Aim: The primary aim of this study was to assess the efficacy of a bismuth-based quadruple regimen as first-line therapy for Helicobacter pylori (HP) eradication in diabetes mellitus (DM) patients. The secondary aim was to study the effect of HP eradication on dyspeptic symptoms in DM patients. Method: Eighty-nine consecutive type 2 DM and 48 non-diabetic age- and sex-matched patients were enrolled in this study. Diabetic patients were randomized to receive either pantoprazole (40 mg b.i.d.), clarithromycin (500 mg b.i.d.), and amoxicillin (1 g b.i.d., PCA-DM group) for 14 days, or pantoprazole (40 mg b.i.d.), bismuth citrate (400 mg b.i.d.), tetracycline (500 mg q.i.d.), and metronidazole (500 mg b.i.d., PBTM-DM group) for 14 days as the eradication regimen. All non-diabetic patients were treated by quadruple therapy (PBTM-non-DM group) for 14 days. We used the validated Leeds Dyspepsia Questionnaire (LDQ) to assess dyspeptic symptoms at baseline and 6 weeks after the end of treatment. Results: The HP eradication rates with intention-to-treat (ITT) and per-protocol (PP) analyses were 51% (for both) in the PCA-DM group; 81 and 85% in the PBTM-DM group, and 85 and 87% in the PBTM-non-DM group. The eradication rates are not different between the PBTM-DM and PBTM-non-DM groups (p > 0.05). The eradication rate was significantly lower in the PCA-DM group with both ITT and PP analysis than in the PBTM-DM and PBTM-non-DM groups (p < 0.05). LDQ score was 4.53 ± 7.7 in DM patients with successful eradication and 14.68 ± 5.9 in DM patients without successful eradication (p < 0.05). Conclusion: The bismuth-based quadruple eradication regimen as first-line therapy is safe, tolerable and achieves a high cure rate in patients with DM, and successful eradication may be beneficial on dyspeptic symptoms.

19 June 2019 in Cutaneous and Ocular Toxicology
Verified
Journal Article
Closed access
UYUğur Yılmaz
Uğur Yılmaz
HKHüseyin Kaya
Hüseyin Kaya
MTMurat Turan
Murat Turan
FBFerda Bir
Ferda Bir
BŞBarbaros Şahin
Barbaros Şahin
Purpose: To investigate the effect of Hypericum Perforatum on corneal alkali burn. Method: We studied 45, 250 grams weighing, 4 months old Wistar Albino rats. Alkaline burns were performed in the corneas of all experimental animals with 2 mol/L NaOH after general anesthesia. Rats were divided into five groups according to the subsequent process applied to them: group 1 was the topical Hypericum perforatum group, group 2 was the topical pure olive oil group, group 3 was the oral Hypericum perforatum group, group 4 was the oral pure olive oil group and group 5 was the control untreated group. Rats were sacrificed under general anesthesia on the fourteenth day. The rate of corneal inflammation, neovascularization, fibroblastic activity, and CD31 staining was investigated. Result: There were 45 rats at the beginning of the study. One rat in group 1, 2, and 3 died during the study; therefore, 42 rats could be evaluated. There were 8 rats in group 1, 8 rats in group 2, 9 rats in group 3, and 8 rats in group 4. We found less CNV, inflammation, and fibroblastic activity in group 1 and group 2 than in the other groups(p˂0.001 for all parameters). CNV, inflammation, fibroblastic activity, and CD31 staining rates were lower in group 1 than in group 2(p˂0.001 for all parameters). There was no difference between groups 3, 4, and 5(respectively, p = 0.436, 0.634, 0.750). Conclusion: We found that both topical Hypericum perforatum oily extract and olive oil have anti-inflammatory, anti-angiogenic and anti-fibroblastic effects when applied after corneal alkali burns in rat corneas. Further studies should be conducted in this field.

19 January 2024 in Medicine
Verified
Journal Article
Open access
UYUğur Yilmaz
Uğur Yilmaz
TATahsin AKÇAOĞLU
Tahsin AKÇAOĞLU
MAMurat Avni Avunduk
Murat Avni Avunduk
HKHüseyin Kaya
Hüseyin Kaya
OPOsman PARCA
Osman PARCA
Vitreous hemorrhage (VH) is one of the main causes of vision loss in diabetic retinopathy (DRP). Early surgery increases the visibility of the retina, allowing early recognition of DRP complications and additional treatments. One of the most important reasons affecting success after surgery is recurrent vitreous hemorrhage (RVH). We aimed to investigate the risk factors for RVH after early 25G vitrectomy in diabetic VH. Eighty eyes of eighty patients who underwent early 25G PPV surgery with a diagnosis of VH due to proliferative diabetic retinopathy (PDR) were included in this retrospective study. Vision acuity changes and intraocular pressure (IOP) changes were compared. The effect of arterial hypertension (HT), coronary artery disease (CAD), preoperative antiglaucomatous usage, and anticoagulant usage on RVH was investigated. A value of P < .05 was accepted as statistically significant. Postoperative RVH was observed in 18 (22.5%) patients. There was no correlation between the age of the patients and the development of postoperative RVH (r = −0.197, P = .08). The rate of HT and the mean HbA1C levels were found to be higher in the patients who developed RVH than in those who did not (P = .04 and < 0.001, respectively). The presence of CAD, preoperative glaucoma disease, and the use of anticoagulants did not have any effect on RVH (P = .229, 0.843, 0.932, respectively). HT and increased HbA1c were found to be risk factors for RVH in VH patients who underwent 25G vitrectomy in the early period in our study.